electroCore to Participate at Canaccord Genuity 42nd Annual Growth Conference
Canaccord Genuity 42nd Annual Growth Conference
Webcast: Canaccord Webcast
Following the conferences, a webcast replay of the presentations will be available on the Investor section of the company’s website, electroCore.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.
For more information, visit www.electrocore.com.